IRCT138902113799N2Other未知
The efficacy of intramyocardial injection of bone marrow-derived mesenchymal and CD133+ stem cells on improvement of cardiac ejection fraction in patients undergoing CABG in Shariati Hospital
Technology cooperation office of Persidency0 个研究点目标入组 9 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- Other
- 发起方
- 入组人数
- 9
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30 years 至 70 years（—）
- 性别
- All
入选标准
- •Inclusion Criteria:
- •1- Candidate for Coronary Artery Bypass Surgery (CABG)
- •2- History of Myocardial Infarction in 2-12 weeks ago
- •3- Age: 30-70 years
- •4- Ejection Fraction (EF) < %40 in Doppler Echocardiography
- •5- Presence of Akinesia in Doppler Echocardiography
- •6- Informed Consentience for this research
排除标准
- •1- Age < 30 yrs. or >70 yrs.
- •2- Unsuitable for Coronary Artery Bypass Surgery (CABG)
- •3- Patients with severe co-morbidity or history of open heart surgery
- •4- Absence of Scar in Scintigraphy Radio-nucleotide Scan
- •5- Patient in cardiac shock or needs for emergency heart surgery
- •6- Patient with moderate to severe valvular disease
- •7- In-consentience for this research
研究者
相似试验
招募中
不适用
Intramyocardial injection of autologous bone marrow cells in no-option patients with refractory angina pectoris and documented ischemia; a registry.bone marrow cells, stem cell therapy, refractory angina, intramyocardial injectionNL-OMON28156eiden University Medical Center (LUMC), Department of Cardiology150
进行中（未招募）
3 期
Intramyocardial TransPlantation Of BonE MaRrow Stem Cells For ImprovEment Of Post-Infarct MyoCardial RegeneraTion In Addition To CABG Surgery: a controlled prospective, randomized, double blinded multicenter trial. (PERFECT)Patients with coronary artery disease scheduled for CABG surgeryDRKS00000213Miltenyi Biotec GmbH82
进行中（未招募）
不适用
Efficacy assessment of repeat intramyocardial injection of autologous bone marrow cells in previously responding no-option patients with residual refractory angina pectoris and documented ischemia - Repeat cell therapy for refractory anginaIn coronary artery disease atherosclerosis leads to a decrease in lumen diameter of the large epicardial arteries, causing a deficit in blood flow known as ischemia. This ischemia can cause chest pain, referred to as angina pectoris. Refractory angina pectoris is a disabling condition with an adverse prognosis with a high mortality rate. This severe disorder has a significant morbidity and impact on quality of life. Many patients have very limiting complaints, despite optimal medical therapy.EUCTR2009-017924-18-NL23
已完成
不适用
Effect of HCG (human chorionic gonadotropin) injection on clinical pregnancy in ART (Assisted Reproductive Technology) cyclesinfertility.female infertility associated with male factorIRCT2014050316912N2Vice Chancellor for Research , Tehran University of Medical Sceinces200
招募中
3 期
Evaluation of efficacy of intramuscular injection of pantothinic acid in patients with mild to moderate acneIRCT20150825023753N19Shiraz University of Medical Sciences60